Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- Both men and women are eligible
- People who have been newly diagnosed with active mild or moderate ulcerative colitis, diagnosed according to American College of Gastroenterology guidelines
- People currently being treated with a medication called mesalamine (also known as 5-aminosalicylic acid)
Who may not be able to join:
- People with severe ulcerative colitis
- People who have been diagnosed with colorectal cancer
- People currently using steroid treatments, whether taken by mouth/injection or used rectally
- People currently using immunosuppressant medications or biological therapies
- People whose treatment with a medication called sulphasalazine has previously not worked
- People with a known allergy to the medications used in the study
- People who have had surgery to remove all or part of their colon
- People with significant liver disease, such as liver fibrosis, cirrhosis, NASH, or NAFLD
- People with other inflammatory diseases
- People with thyroid disease
- People with heart conditions including irregular heartbeat, reduced blood flow to the heart, or heart failure
- People with diabetes
- People currently taking antioxidant supplements, including vitamins A, C, or E, selenium, or co-enzyme Q
- People currently taking any of the following medications: amlodipine, levothyroxine, low-dose aspirin, warfarin, atorvastatin, insulin, oral diabetes medications, or chemotherapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +201067988063
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in both health related quality of life; Change in disease severity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.